4.3 Review

Pain in early-stage Parkinson's disease: Implications from clinical features to pathophysiology mechanisms

期刊

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
卷 116, 期 8, 页码 571-581

出版社

ELSEVIER TAIWAN
DOI: 10.1016/j.jfma.2017.04.024

关键词

Parkinson's disease; Pain; Early stage; Nociceptive pathway; Sensory

向作者/读者索取更多资源

Pain is a common non-motor symptom of Parkinson's disease (PD) that markedly impacts patients' quality of life. Although pain occurs mostly secondary to motor disability of PD, pain may antedate motor symptoms by years. Numerous studies have shown that PD patients manifest altered sensory and pain thresholds compared with control subjects. Although both levodopa and deep brain stimulation improve motor symptoms, there remains no direct correlation between motor improvement and altered pain sensitivity, suggesting that motor symptoms and pain do not necessarily share pathogenetic mechanisms. Whether nociceptive processing is dysfunctional in the early stages of PD, when motor symptoms are not prominent, remains uncertain. In this review, we highlight the evidence for disrupted nociceptive processing in patients with early-stage PD. Painful symptoms and aberrant pain processing in early PD are associated with both central and peripheral deafferentation. Dopamine depletion in selective striatal regions, and the development of Lewy pathology in specific non-dopaminergic subcortical areas, underlie the clinical features of pain at this early disease stage. An increased awareness of pain as an early feature of PD might provide further insights into a mechanism-based approach to sensory system dysregulation in this disease. Copyright (C) 2017, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Geriatrics & Gerontology

Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease

Chao-Wen Lin, Tzu-Ting Lai, Szu-Ju Chen, Chin-Hsien Lin

Summary: The levels of alpha-synuclein and NfL in tears as well as retinal microvascular densities are associated with the risk and progression of Parkinson's disease.

GEROSCIENCE (2022)

Article Clinical Neurology

COQ2 and SNCA polymorphisms interact with environmental factors to modulate the risk of multiple system atrophy and subtype disposition

Ming-Che Kuo, Ying-Che Lu, Chun-Hwei Tai, Bing-Wen Soong, Fu-Chang Hu, Meng-Ling Chen, Chin-Hsien Lin, Ruey-Meei Wu

Summary: This study investigated the integrated effect of genetic and environmental factors on the etiology of multiple system atrophy (MSA). The results showed that certain genetic variations and environmental factors interact to modulate the risk and subtype disposition of MSA. Further investigation is needed to understand the underlying mechanisms of these gene-environment interactions in MSA etiopathogenesis.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Article Clinical Neurology

A task-specific cognitive domain decline is correlated with plasma and neuroimaging markers in patients with Parkinson's disease

Cheng-Hsuan Li, Ta-Fu Chen, Pei-Ling Peng, Chin-Hsien Lin

Summary: Cognitive decline in Parkinson's disease patients is correlated with neuroimaging and plasma biomarkers in specific cognitive domains.

JOURNAL OF NEUROLOGY (2022)

Review Medicine, General & Internal

Gut-oriented disease modifying therapy for Parkinson's disease

Chin-Hsien Lin, Hsin-Chih Lai, Ming-Shiang Wu

Summary: Neuropathology studies have found that Parkinson's disease may originate in the gut enteric nervous system and spread to the central dopaminergic neurons through the gut-brain axis. The gut microbiomes and metabolites of PD patients have been found to be different from unaffected controls. Targeting the gut microbiota as a potential disease-modifying therapy for PD has been suggested, especially for patients whose disease begins in the gut.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2023)

Letter Clinical Neurology

Genetic analysis of IMPDH2 gene in Taiwanese patients with isolated or combined dystonia

Pin-Shiuan Chen, Meng-Chen Wu, Chun-Hwei Tai, Yung-Yee Chang, Min-Yu Lan, Ying-Fa Chen, Han- Lin, Ni-Chung Lee, Chin-Hsien Lin

Summary: We investigated 245 Taiwanese patients with dystonia and found no evidence to suggest a link between the inosine monophosphate dehydrogenase gene (IMPDH2) and the disease, suggesting that IMPDH2 may not play a major role in dystonia.

PARKINSONISM & RELATED DISORDERS (2023)

Article Clinical Neurology

The MAPT p.P301L mutation presents as a rare early-onset corticobasal syndrome: A case report

Cheng-Hsuan Li, Ni-Chung Lee, Kun-Ju Lin, Ing-Tsung Hsiao, Yi-Hsin Weng, Chin-Hsien Lin

Summary: This article reported a 49-year-old Taiwanese woman with a three-year history of progressive right-hand dystonia and slowness of gait, who also had a family history of autosomal-dominant parkinsonism. Genetic analysis revealed a pathogenic heterozygous missense variant on exon 10 of the MAPT gene, expanding the phenotypic spectrum of the MAPT p.P301L mutation. Our findings highlighted the heterogeneity of this rare genetic variant and suggested that MAPT mutations should be considered in Asian patients with early-onset or familial CBS.

NEUROLOGY ASIA (2023)

Article Clinical Neurology

Irritable bowel syndrome based on Rome IV diagnostic criteria associates with non-motor symptoms of Parkinson's disease

Yi-Cheng Tai, Peng-Hsiang Liao, Valentina Leta, Chin-Hsien Lin, K. Ray Chaudhuri

Summary: This study investigated the prevalence of functional gastrointestinal disorders in Parkinson's disease (PD) patients and its correlation with the clinical severity of PD. The results showed that constipation and irritable bowel syndrome (IBS) were more common in PD patients than controls. The severity of IBS was associated with non-motor symptom burden, especially mood symptoms, while the severity of constipation was correlated with motor symptom severity.

PARKINSONISM & RELATED DISORDERS (2023)

Article Clinical Neurology

A novel C19orf12 frameshift mutation in a MPAN pedigree impairs mitochondrial function and connectivity leading to neurodegeneration

Huan-Yun Chen, Han- Lin, Chia-Lang Hsu, Pei-Lung Chen, Cheng-Yen Huang, Shu-Chun Teng, Chin-Hsien Lin

Summary: A novel heterozygous mutation in the C19orf12 gene, c273_274 insA (p.P92Tfs*9), was identified in a Taiwanese family with autosomal dominant MPAN. This study provided clinical, genetic, and mechanistic insights into the pathogenesis of MPAN, highlighting the importance of mitochondrial dysfunction.

PARKINSONISM & RELATED DISORDERS (2023)

Article Clinical Neurology

Clinical Characteristics, Genetic Features, and Long-Term Outcome of Wilson's Disease in a Taiwanese Population: An 11-Year Follow

Sung -Pin Fan, Yih-Chih Kuo, Ni-Chung Lee, Yin-Hsiu Chien, Wuh-Liang Hwu, Yu-Hsuan Huang, Han- Lin, Tai -Chung Tseng, Tung -Hung Su, Shiou-Ru Tzeng, Chien -Ting Hsu, Huey -Ling Chen, Chin-Hsien Lin, Yen-Hsuan Ni

Summary: In this retrospective analysis, the clinical characteristics and long-term outcomes of a large cohort of WD patients were determined. Differences were observed between the neuro-psychiatric group and the hepatic group in terms of presentation, neuroimaging, genetic information, and prognosis. The findings suggest that the clinical characteristics and prognosis of WD are influenced by ethnic differences.

JOURNAL OF MOVEMENT DISORDERS (2023)

Review Clinical Neurology

Genetic Movement Disorders Commonly Seen in Asians

Priya Jagota, Shen-Yang Lim, Pramod Kumar Pal, Jee-Young Lee, Prashanth Lingappa Kukkle, Shinsuke Fujioka, Huifang Shang, Onanong Phokaewvarangkul, Roongroj Bhidayasiri, Norlinah Mohamed Ibrahim, Yoshikazu Ugawa, Zakiyah Aldaajani, Beomseok Jeon, Cid Diesta, Cholpon Shambetova, Chin-Hsien Lin

Summary: The increasing availability of molecular genetic testing has changed the landscape of both genetic research and clinical practice. These advancements lead to the awareness that some genetic movement disorders may cluster in certain ethnic populations and genetic pleiotropy may result in unique clinical presentations in specific ethnic groups. Recognition of a particular clinical phenotype, combined with information about the ethnic origin of patients could lead to early and correct diagnosis and assist the development of future personalized medicine for patients with these disorders.

MOVEMENT DISORDERS CLINICAL PRACTICE (2023)

Article Clinical Neurology

Blood neurofilament light chain as a surrogate marker for dystonia

Meng-Chen Wu, Yung-Yee Chang, Min-Yu Lan, Ying-Fa Chen, Chun-Hwei Tai, Szu-Ju Chen, Chin-Hsien Lin

Summary: This study aimed to investigate whether plasma NfL levels were elevated and associated with disease severity in patients with dystonia. The results showed that plasma NfL levels were significantly higher in those with generalized dystonia compared to those with focal dystonia or controls, while the level was comparable between the focal dystonia group and controls. Furthermore, the dystonia combined with parkinsonism group had higher NfL levels than the isolated dystonia group. This suggests that neurodegeneration is involved in the disease process of this subgroup of patients.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Clinical Neurology

Substantia nigra nigrosome-1 imaging correlates with the severity of motor symptoms in Parkinson's disease

Yung-Tsai Chu, Chin-Feng Yu, Sung-Pin Fan, Ta-Fu Chen, Ming-Jang Chiu, Jyh-Shing Roger Jang, Shu- Chiu, Chin-Hsien Lin

Summary: This study found that the size of nigrosome-1 is significantly smaller in PD patients compared to controls. The loss and size of nigrosome-1 may potentially assist in the diagnosis of PD and reflect the motor severity of the disease.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Article Multidisciplinary Sciences

Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing

Hsiu-Hui Tsai, Hsiao-Jung Kao, Ming-Wei Kuo, Chin-Hsien Lin, Chun-Min Chang, Yi-Yin Chen, Hsiao-Huei Chen, Pui-Yan Kwok, Alice L. Yu, John Yu

Summary: CRISPR-Cas9 genome editing has potential therapeutic applications, but safety concerns arise. Whole genomic analysis reveals large chromosomal deletions at non-homologous off-target sites, limiting the usefulness of CRISPR-Cas9 editing in disease modeling and gene therapy. Ensuring genome integrity after editing is crucial for minimizing unintended effects in research and clinical applications.

NATURE COMMUNICATIONS (2023)

Review Cell Biology

Gut microenvironmental changes as a potential trigger in Parkinson's disease through the gut-brain axis

Szu-Ju Chen, Chin-Hsien Lin

Summary: Parkinson's disease is the second most common neurodegenerative disease, influenced by both genetic risk and environmental factors. While motor dysfunction is the main characteristic, the disease process involves multiple systems and shows heterogenous clinical presentation and progression. Genetic predisposition to Parkinson's disease includes abnormal immune responses, protein aggregation, autophagolysosomal impairment, and mitochondrial dysfunction, leading to vulnerable neurons that are sensitive to environmental triggers. Changes in the gut microenvironment may potentially act as a trigger in genetically susceptible individuals.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

Article Computer Science, Information Systems

Early Detection of Parkinson's Disease by Neural Network Models

Chin-Hsien Lin, Fu-Cheng Wang, Tien-Yun Kuo, Po-Wei Huang, Szu-Fu Chen, Li-Chen Fu

Summary: This study developed neural network models that can identify Parkinson's disease (PD) and differentiate patients at different severity stages. The models achieved high accuracy in recognizing advanced-stage PD patients and distinguishing early-stage PD patients from normal elderly subjects.

IEEE ACCESS (2022)

暂无数据